APA (7th ed.) Citation

Bestwick, R., Bhogal, R., Kildonaviciute, K., Ng, B. Y., Jackson, B., Moriarty, C., . . . Mujica‐Mota, R. (2025). An Economic Evaluation of Direct Oral Penicillin Challenge for De‐Labelling Low Risk Patients With a Penicillin Allergy Label. Clinical & Experimental Allergy, 55(5), 378. https://doi.org/10.1111/cea.14633

Chicago Style (17th ed.) Citation

Bestwick, R., et al. "An Economic Evaluation of Direct Oral Penicillin Challenge for De‐Labelling Low Risk Patients With a Penicillin Allergy Label." Clinical & Experimental Allergy 55, no. 5 (2025): 378. https://doi.org/10.1111/cea.14633.

MLA (9th ed.) Citation

Bestwick, R., et al. "An Economic Evaluation of Direct Oral Penicillin Challenge for De‐Labelling Low Risk Patients With a Penicillin Allergy Label." Clinical & Experimental Allergy, vol. 55, no. 5, 2025, p. 378, https://doi.org/10.1111/cea.14633.